These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9384694)

  • 1. The molecular basis of carcinogenesis: understanding the cell cycle clock.
    Weinberg RA
    Cytokines Mol Ther; 1996 Jun; 2(2):105-10. PubMed ID: 9384694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
    Yu Q; Ciemerych MA; Sicinski P
    Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of the cell cycle in cancer.
    Sandhu C; Slingerland J
    Cancer Detect Prev; 2000; 24(2):107-18. PubMed ID: 10917130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
    Lodén M; Stighall M; Nielsen NH; Roos G; Emdin SO; Ostlund H; Landberg G
    Oncogene; 2002 Jul; 21(30):4680-90. PubMed ID: 12096344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implication of cell cycle regulating genes in carcinogenesis].
    Hanada N; Saya H
    Tanpakushitsu Kakusan Koso; 1995 Aug; 40(11):1713-20. PubMed ID: 7676032
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclins, CDKs and cancer.
    Pines J
    Semin Cancer Biol; 1995 Apr; 6(2):63-72. PubMed ID: 7647308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclins and breast cancer.
    Sutherland RL; Musgrove EA
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):95-104. PubMed ID: 15082921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle exit upon myogenic differentiation.
    Walsh K; Perlman H
    Curr Opin Genet Dev; 1997 Oct; 7(5):597-602. PubMed ID: 9388774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [G1-cyclin/Cdk and cancer].
    Takahashi H; Matsushime H
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1554-61. PubMed ID: 9279081
    [No Abstract]   [Full Text] [Related]  

  • 20. The cell cycle in growth and development: a special issue.
    Wilkins AS
    Bioessays; 1995 Jun; 17(6):469-70. PubMed ID: 7575487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.